Literature DB >> 7325641

Cefoxitin pharmacokinetics: relation to three different renal clearance studies in patients with various degrees of renal insufficiency.

D Kampf, R Schurig, I Korsukewitz, O Brückner.   

Abstract

The pharmacokinetics of cefoxitin were examined in 4 healthy volunteers, 6 patients with normal renal function (inulin clearance, greater than 80 ml/min per 1.73 m2), and 35 patients with various degrees of renal insufficiency (inulin clearance, 80 to less than 5 ml/min per 1.73 m2). A single dose of 30 mg of cefoxitin per kg of body weight was injected intravenously over 3 min. Antibiotic concentrations in plasma were determined by the agar diffusion technique. The cefoxitin half-life increased progressively from 39 min in subjects with normal renal function to 23.5 h in oligoanuric patients. Correspondingly, total body clearance decreased from 340 to 13 ml/min per 1.73 m2. In addition to the study of cefoxitin kinetics, in 29 of the 41 patients, three different renal clearance tests were performed (inulin, p-aminohippurate, and creatinine clearances). Of these, p-aminohippurate clearance showed the best correlation with the elimination rate constant beta as well as total body clearance of cefoxitin; but with respect to beta, the differences between the p-aminohippurate and creatinine clearances were quantitatively negligible. Therefore, even in substances which are eliminated predominantly by active tubular secretion, creatinine clearance could be recommended for dosage adjustments.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7325641      PMCID: PMC181793          DOI: 10.1128/AAC.20.6.741

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Relationship between the transport and toxicity of cephalosporins in the kidney.

Authors:  B M Tune
Journal:  J Infect Dis       Date:  1975-08       Impact factor: 5.226

2.  The pathologic physiology of chronic Bright's disease. An exposition of the "intact nephron hypothesis".

Authors:  N S BRICKER; P A MORRIN; S W KIME
Journal:  Am J Med       Date:  1960-01       Impact factor: 4.965

3.  Body composition in chronic renal failure.

Authors:  G A Coles
Journal:  Q J Med       Date:  1972-01

4.  Relationship between cephaloridine and p-aminohippurate transport in the kidney.

Authors:  B M Tune; M Fernholt
Journal:  Am J Physiol       Date:  1973-11

5.  The binding of drugs to plasma proteins and the interpretation of measurements of plasma concentrations of drugs in patients with poor renal function.

Authors:  M M Reidenberg
Journal:  Am J Med       Date:  1977-04       Impact factor: 4.965

6.  [Correlation of thromboplastin times in dicumarol treated patients using various preparations of thrombokinase].

Authors:  R Averdunk; K Borner
Journal:  Z Klin Chem Klin Biochem       Date:  1970-05

7.  Effects of uremic sera on renal tubular P-aminohippurate transport.

Authors:  H G Preuss; S G Massry; J F Maher; M Gilliece; G E Schreiner
Journal:  Nephron       Date:  1966       Impact factor: 2.847

Review 8.  Renal failure, drug pharmacokinetics and drug action.

Authors:  J Fabre; L Balant
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

Review 9.  Drug dosage in renal disease.

Authors:  L Dettli
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

10.  Renal tubular handling of drugs.

Authors:  E J Cafruny
Journal:  Am J Med       Date:  1977-04       Impact factor: 4.965

View more
  7 in total

1.  Anti-anaerobic antimicrobial agents: cefoxitin, cefotetan, clindamycin, and metronidazole.

Authors:  J A Bosso; R A Prince
Journal:  Tex Heart Inst J       Date:  1990

2.  Cefoxitin Plasma and Subcutaneous Adipose Tissue Concentration in Patients Undergoing Sleeve Gastrectomy.

Authors:  Luigi Brunetti; Leonid Kagan; Glenn Forrester; Lauren M Aleksunes; Hongxia Lin; Steven Buyske; Ronald G Nahass
Journal:  Clin Ther       Date:  2015-12-11       Impact factor: 3.393

Review 3.  Guide to drug dosage in renal failure.

Authors:  W M Bennett
Journal:  Clin Pharmacokinet       Date:  1988-11       Impact factor: 6.447

4.  Population pharmacokinetics of prophylactic cefoxitin in patients undergoing colorectal surgery.

Authors:  Arantxazu Isla; Iñaki F Trocóniz; Ignacio López de Tejada; Silvia Vázquez; Andrés Canut; Jesús Muriel López; María Ángeles Solinís; Alicia Rodríguez Gascón
Journal:  Eur J Clin Pharmacol       Date:  2012-01-15       Impact factor: 2.953

5.  Applications of minimal physiologically-based pharmacokinetic models.

Authors:  Yanguang Cao; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-11-23       Impact factor: 2.745

6.  A Physiologically-Based Pharmacokinetic Framework for Prediction of Drug Exposure in Malnourished Children.

Authors:  Erik Sjögren; Joel Tarning; Karen I Barnes; E Niclas Jonsson
Journal:  Pharmaceutics       Date:  2021-02-02       Impact factor: 6.321

7.  Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study.

Authors:  Paul Chabert; Judith Provoost; Sabine Cohen; Céline Dupieux-Chabert; Laurent Bitker; Tristan Ferry; Sylvain Goutelle; Jean-Christophe Richard
Journal:  Ann Intensive Care       Date:  2022-09-30       Impact factor: 10.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.